For help on how to get the results you want, see our search tips.
1845 results
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan anhydrous free-base, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,
, Revision: 10, Authorised, Last updated: 08/10/2021
-
List item
Human medicine European public assessment report (EPAR): Cubicin (updated)
daptomycin, Gram-Positive Bacterial Infections; Bacteremia; Soft Tissue Infections; Endocarditis, Bacterial
Date of authorisation: 19/01/2006, Revision: 36, Authorised, Last updated: 08/10/2021 -
List item
Human medicine European public assessment report (EPAR): Azarga (updated)
brinzolamide, timolol maleate, Glaucoma, Open-Angle; Ocular Hypertension
Date of authorisation: 25/11/2008, Revision: 14, Authorised, Last updated: 08/10/2021 -
List item
Human medicine European public assessment report (EPAR): DuoTrav (updated)
travoprost, timolol, Glaucoma, Open-Angle; Ocular Hypertension
Date of authorisation: 23/04/2006, Revision: 18, Authorised, Last updated: 08/10/2021 -
List item
Human medicine European public assessment report (EPAR): Dectova (updated)
Zanamivir, Influenza, Human
Date of authorisation: 26/04/2019,
, Revision: 4, Authorised, Last updated: 08/10/2021
-
List item
Human medicine European public assessment report (EPAR): Comirnaty (updated)
Single-stranded, 5’-capped messenger RNA produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2, COVID-19 virus infection
Date of authorisation: 21/12/2020,, 
, Revision: 13, Authorised, Last updated: 08/10/2021
-
List item
Human medicine European public assessment report (EPAR): Ranexa (previously Latixa) (updated)
ranolazine, Angina Pectoris
Date of authorisation: 08/07/2008, Revision: 20, Authorised, Last updated: 08/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Advocate (updated)
imidacloprid, moxidectin, Dogs; Cats; Ferrets
Date of authorisation: 02/04/2003, Revision: 23, Authorised, Last updated: 08/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Arti-Cell Forte (updated)
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells, Horses
Date of authorisation: 29/03/2019, Revision: 4, Authorised, Last updated: 08/10/2021 -
List item
Human medicine European public assessment report (EPAR): Cyramza (updated)
Ramucirumab, Stomach Neoplasms
Date of authorisation: 19/12/2014, Revision: 12, Authorised, Last updated: 08/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Virbagen Omega (updated)
recombinant omega interferon of feline origin, Dogs; Cats
Date of authorisation: 05/11/2001, Revision: 12, Authorised, Last updated: 07/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Nobivac LeuFel (updated)
purified Rp-45 FeLV-envelope antigen, Cats
Date of authorisation: 06/11/2017, Revision: 3, Authorised, Last updated: 07/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Leucofeligen FeLV/RCP (updated)
purified p45 feline leukaemia virus envelope antigen, live feline calicivirus (strain F9), live feline viral rhinotracheitis virus (strain F2), live feline panleucopenia virus, Cats
Date of authorisation: 24/06/2009, Revision: 9, Authorised, Last updated: 07/10/2021 -
List item
Veterinary medicine European public assessment report (EPAR): Leucogen (updated)
purified p45 FeLV-envelope antigen, Cats
Date of authorisation: 17/06/2009, Revision: 8, Authorised, Last updated: 07/10/2021 -
List item
Human medicine European public assessment report (EPAR): Intuniv (updated)
guanfacine hydrochloride, Attention Deficit Disorder with Hyperactivity
Date of authorisation: 17/09/2015,, Revision: 8, Authorised, Last updated: 07/10/2021
-
List item
Human medicine European public assessment report (EPAR): Zalviso (updated)
sufentanil, Pain, Postoperative
Date of authorisation: 18/09/2015, Revision: 7, Authorised, Last updated: 07/10/2021 -
List item
Human medicine European public assessment report (EPAR): Zydelig (updated)
Idelalisib, Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 18/09/2014,, Revision: 19, Authorised, Last updated: 06/10/2021
-
List item
Human medicine European public assessment report (EPAR): Tyverb (updated)
lapatinib, Breast Neoplasms
Date of authorisation: 10/06/2008, Revision: 32, Authorised, Last updated: 06/10/2021 -
List item
Human medicine European public assessment report (EPAR): Cometriq (updated)
cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014,, , , Revision: 23, Authorised, Last updated: 06/10/2021
-
List item
Human medicine European public assessment report (EPAR): Febuxostat Mylan (updated)
febuxostat, Hyperuricemia; Arthritis, Gouty; Gout
Date of authorisation: 15/06/2017,
, Revision: 5, Authorised, Last updated: 06/10/2021
-
List item
Human medicine European public assessment report (EPAR): SomaKit TOC (updated)
edotreotide, Neuroendocrine Tumors; Radionuclide Imaging
Date of authorisation: 08/12/2016,, , Revision: 9, Authorised, Last updated: 06/10/2021
-
List item
Human medicine European public assessment report (EPAR): RoActemra (updated)
tocilizumab, Arthritis, Rheumatoid; Arthritis, Juvenile Rheumatoid
Date of authorisation: 15/01/2009, Revision: 34, Authorised, Last updated: 06/10/2021 -
List item
Human medicine European public assessment report (EPAR): Rivastigmine Sandoz (updated)
rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 10/12/2009, Revision: 12, Authorised, Last updated: 05/10/2021 -
List item
Human medicine European public assessment report (EPAR): Humalog (updated)
insulin lispro, Diabetes Mellitus
Date of authorisation: 30/04/1996, Revision: 34, Authorised, Last updated: 05/10/2021 -
List item
Human medicine European public assessment report (EPAR): Gefitinib Mylan (updated)
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 27/09/2018,, Revision: 2, Authorised, Last updated: 05/10/2021